266 related articles for article (PubMed ID: 11145693)
1. Transcriptional down-regulation of CXC chemokine receptor 4 induced by impaired association of transcription regulator YY1 with c-Myc in human herpesvirus 6-infected cells.
Hasegawa A; Yasukawa M; Sakai I; Fujita S
J Immunol; 2001 Jan; 166(2):1125-31. PubMed ID: 11145693
[TBL] [Abstract][Full Text] [Related]
2. Carboxyl-terminal Src kinase homologous kinase negatively regulates the chemokine receptor CXCR4 through YY1 and impairs CXCR4/CXCL12 (SDF-1alpha)-mediated breast cancer cell migration.
Lee BC; Lee TH; Zagozdzon R; Avraham S; Usheva A; Avraham HK
Cancer Res; 2005 Apr; 65(7):2840-5. PubMed ID: 15805285
[TBL] [Abstract][Full Text] [Related]
3. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry.
Moriuchi M; Moriuchi H; Margolis DM; Fauci AS
J Immunol; 1999 May; 162(10):5986-92. PubMed ID: 10229837
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc.
Shrivastava A; Saleque S; Kalpana GV; Artandi S; Goff SP; Calame K
Science; 1993 Dec; 262(5141):1889-92. PubMed ID: 8266081
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7.
Yasukawa M; Hasegawa A; Sakai I; Ohminami H; Arai J; Kaneko S; Yakushijin Y; Maeyama K; Nakashima H; Arakaki R; Fujita S
J Immunol; 1999 May; 162(9):5417-22. PubMed ID: 10228019
[TBL] [Abstract][Full Text] [Related]
6. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc.
Austen M; Cerni C; Lüscher-Firzlaff JM; Lüscher B
Oncogene; 1998 Jul; 17(4):511-20. PubMed ID: 9696045
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cell growth by the Myc-Max-Mad network: role of Mad proteins and YY1.
Austen M; Cerni C; Henriksson M; Hilfenhaus S; Lüscher-Firzlaff JM; Menkel A; Seelos C; Sommer A; Lüscher B
Curr Top Microbiol Immunol; 1997; 224():123-30. PubMed ID: 9308235
[No Abstract] [Full Text] [Related]
8. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
9. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.
Hurlin PJ; Ayer DE; Grandori C; Eisenman RN
Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059
[TBL] [Abstract][Full Text] [Related]
10. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
11. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
[TBL] [Abstract][Full Text] [Related]
12. The c-myc protein represses the lambda 5 and TdT initiators.
Mai S; Mårtensson IL
Nucleic Acids Res; 1995 Jan; 23(1):1-9. PubMed ID: 7870572
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators.
Sommer A; Bousset K; Kremmer E; Austen M; Lüscher B
J Biol Chem; 1998 Mar; 273(12):6632-42. PubMed ID: 9506959
[TBL] [Abstract][Full Text] [Related]
14. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
Ayer DE; Kretzner L; Eisenman RN
Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells.
Garbán HJ; Bonavida B
J Immunol; 2001 Jul; 167(1):75-81. PubMed ID: 11418634
[TBL] [Abstract][Full Text] [Related]
16. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells.
de Nigris F; Botti C; Rossiello R; Crimi E; Sica V; Napoli C
Oncogene; 2007 Jan; 26(3):382-94. PubMed ID: 16878156
[TBL] [Abstract][Full Text] [Related]
17. Dynamic in vivo interactions among Myc network members.
Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
[TBL] [Abstract][Full Text] [Related]
18. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max.
Gu W; Cechova K; Tassi V; Dalla-Favera R
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2935-9. PubMed ID: 8385351
[TBL] [Abstract][Full Text] [Related]
19. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer DE; Eisenman RN
Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
[TBL] [Abstract][Full Text] [Related]
20. CDC6 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc/Max complex.
Takayama M; Taira T; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2000 Jul; 477(1-2):43-8. PubMed ID: 10899308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
